Applied Therapeutics

Price & Volume

Stats

52W Range	$0.29-$10.62
Market Cap	$179.7M
Shares Short	9M

Financials

Revenue (12 Mos)	$121,000
Revenue Growth (YoY)	-98.2%
Gross Profit (12 Mos)	-$44.1M
Diluted EPS	-$0.22

News

Yahoo Finance • 3 days ago

Applied Therapeutics Provides Update Following Meeting with FDA

Yahoo Finance • 15 days ago

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf

Yahoo Finance • 17 days ago

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta Inc. (NYSE: IBTA); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf

Yahoo Finance • 20 days ago

Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf

About

CEO	Mr. Les D. Funtleyder
CFO	Mr. Les D. Funtleyder
Address	545 Fifth Avenue, New York, NY, United States, 10017
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	32